Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1α), in patients with refractory solid tumors

出版年份 2013 全文链接

标题

作者

关键词

Synthetic locked nucleic acid (LNA) oligodeoxynucleotide, Pharmacodynamics-driven trials, Antiangiogenesis, HIF mRNA

出版物

CANCER CHEMOTHERAPY AND PHARMACOLOGY

Volume 73, Issue 2, Pages 343-348

出版商

Springer Nature

发表日期

2013-11-29

DOI

10.1007/s00280-013-2362-z

参考文献

查看 5 条相关文献

向作者/读者发起求助以获取更多资源

Protocol

在线求助

Reagent

在线求助

Reprint

联系作者

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.